These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 21872471)

  • 61. A case of facioscapulohumeral muscular dystrophy and myasthenia gravis with positivity of anti-Ach receptor antibody: a fortuitous association?
    Filippelli E; Barone S; Granata A; Nisticò R; Valentino P
    Neurol Sci; 2019 Jan; 40(1):195-197. PubMed ID: 30215155
    [No Abstract]   [Full Text] [Related]  

  • 62. T-cell recognition of acetylcholine receptor provides a reliable means for monitoring autoimmunity to acetylcholine receptor in antibody-negative myasthenia gravis patients.
    Oshima M; Deitiker PR; Smith RG; Mosier D; Atassi MZ
    Autoimmunity; 2012 Mar; 45(2):153-60. PubMed ID: 21985279
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Quantitative EMG of facial muscles in myasthenia patients with MuSK antibodies.
    Farrugia ME; Kennett RP; Hilton-Jones D; Newsom-Davis J; Vincent A
    Clin Neurophysiol; 2007 Feb; 118(2):269-77. PubMed ID: 17157556
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Acetylcholine receptor-induced experimental myasthenia gravis: what have we learned from animal models after three decades?
    Baggi F; Antozzi C; Toscani C; Cordiglieri C
    Arch Immunol Ther Exp (Warsz); 2012 Feb; 60(1):19-30. PubMed ID: 22159475
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Amyotrophic lateral sclerosis with positive anti-acetylcholine receptor antibodies. Case report and review of the literature.
    Mehanna R; Patton EL; Phan CL; Harati Y
    J Clin Neuromuscul Dis; 2012 Dec; 14(2):82-5. PubMed ID: 23172389
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Facioscapulohumeral muscular dystrophy.
    Padberg GW; van Engelen BG
    Curr Opin Neurol; 2009 Oct; 22(5):539-42. PubMed ID: 19724227
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Late-onset myopathies.
    Salort-Campana E; Attarian S
    Curr Opin Neurol; 2024 Oct; 37(5):523-535. PubMed ID: 39017649
    [TBL] [Abstract][Full Text] [Related]  

  • 68. AChR-seropositive myasthenia gravis in muscular dystrophy: diagnostic pitfalls and clinical management challenges.
    Avallone AR; Di Stefano V; Bevilacqua L; Alonge P; Lupica A; Maccora S; Monastero R; Amabile S; Barone P; Brighina F; Vinciguerra C
    Neurol Sci; 2024 Jul; ():. PubMed ID: 38965114
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Acetylcholine receptor antibodies in patients with genetic myopathies: clinical and biological significance.
    Lane RJ; Roncaroli F; Charles P; McGonagle DG; Orrell RW
    Neuromuscul Disord; 2012 Feb; 22(2):122-8. PubMed ID: 21872471
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Antibody effector mechanisms in myasthenia gravis-pathogenesis at the neuromuscular junction.
    Gomez AM; Van Den Broeck J; Vrolix K; Janssen SP; Lemmens MA; Van Der Esch E; Duimel H; Frederik P; Molenaar PC; Martínez-Martínez P; De Baets MH; Losen M
    Autoimmunity; 2010 Aug; 43(5-6):353-70. PubMed ID: 20380584
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Antibodies in myasthenia gravis].
    Eymard B
    Rev Neurol (Paris); 2009 Feb; 165(2):137-43. PubMed ID: 19162288
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Myasthenia gravis induced by autoantibodies against MuSK].
    Shigemoto K; Konishi T; Ohta M
    Nihon Rinsho; 2008 Jun; 66(6):1149-54. PubMed ID: 18540361
    [TBL] [Abstract][Full Text] [Related]  

  • 73. On the initial trigger of myasthenia gravis and suppression of the disease by antibodies against the MHC peptide region involved in the presentation of a pathogenic T-cell epitope.
    Atassi MZ; Oshima M; Deitiker P
    Crit Rev Immunol; 2001; 21(1-3):1-27. PubMed ID: 11642597
    [TBL] [Abstract][Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.